294 related articles for article (PubMed ID: 21547723)
1. Introduction to section I: overview of approaches to study cystic fibrosis pathophysiology.
Clunes MT; Boucher RC
Methods Mol Biol; 2011; 742():3-14. PubMed ID: 21547723
[TBL] [Abstract][Full Text] [Related]
2. Cystic fibrosis: a disease of vulnerability to airway surface dehydration.
Boucher RC
Trends Mol Med; 2007 Jun; 13(6):231-40. PubMed ID: 17524805
[TBL] [Abstract][Full Text] [Related]
3. [Physiopathology of cystic fibrosis lung disease].
Chinet T
Rev Mal Respir; 1999 Jun; 16(3):339-45. PubMed ID: 10472642
[TBL] [Abstract][Full Text] [Related]
4. Model of mucociliary clearance in cystic fibrosis lungs.
Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
[TBL] [Abstract][Full Text] [Related]
5. [Early bronchial inflammation in cystic fibrosis].
Puchelle E
J Soc Biol; 2002; 196(1):29-35. PubMed ID: 12134630
[TBL] [Abstract][Full Text] [Related]
6. Failure of local defense mechanisms in cystic fibrosis.
Proesmans M; De Boeck K
Acta Otorhinolaryngol Belg; 2000; 54(3):367-72. PubMed ID: 11082773
[TBL] [Abstract][Full Text] [Related]
7. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice.
Mall M; Grubb BR; Harkema JR; O'Neal WK; Boucher RC
Nat Med; 2004 May; 10(5):487-93. PubMed ID: 15077107
[TBL] [Abstract][Full Text] [Related]
8. Rationale for hypertonic saline therapy for cystic fibrosis lung disease.
Tarran R; Donaldson S; Boucher RC
Semin Respir Crit Care Med; 2007 Jun; 28(3):295-302. PubMed ID: 17562499
[TBL] [Abstract][Full Text] [Related]
9. Introduction to section III: resources for CFTR research.
Amaral MD
Methods Mol Biol; 2011; 742():281-3. PubMed ID: 21547739
[TBL] [Abstract][Full Text] [Related]
10. Relationships between cystic fibrosis transmembrane conductance regulator, extracellular nucleotides and cystic fibrosis.
Marcet B; Boeynaems JM
Pharmacol Ther; 2006 Dec; 112(3):719-32. PubMed ID: 16828872
[TBL] [Abstract][Full Text] [Related]
11. Immunopathophysiologic mechanisms of cystic fibrosis lung disease.
Soferman R
Isr Med Assoc J; 2006 Jan; 8(1):44-8. PubMed ID: 16450752
[TBL] [Abstract][Full Text] [Related]
12. [Cystic fibrosis lung disease and its management].
Hidaka N; Hidaka Y
Nihon Rinsho; 1999 Sep; 57(9):2139-44. PubMed ID: 10497420
[TBL] [Abstract][Full Text] [Related]
13. What's new in CF airway inflammation: an update.
Ratjen F
Paediatr Respir Rev; 2006; 7 Suppl 1():S70-2. PubMed ID: 16798601
[TBL] [Abstract][Full Text] [Related]
14. Cystic fibrosis: basic science.
McAuley DF; Elborn JS
Paediatr Respir Rev; 2000 Jun; 1(2):93-100. PubMed ID: 12531100
[TBL] [Abstract][Full Text] [Related]
15. Role of CFTR in airway disease.
Pilewski JM; Frizzell RA
Physiol Rev; 1999 Jan; 79(1 Suppl):S215-55. PubMed ID: 9922383
[TBL] [Abstract][Full Text] [Related]
16. Cystic Fibrosis: Pathophysiology of Lung Disease.
Bergeron C; Cantin AM
Semin Respir Crit Care Med; 2019 Dec; 40(6):715-726. PubMed ID: 31659725
[TBL] [Abstract][Full Text] [Related]
17. Lung disease in mice with cystic fibrosis.
Kent G; Iles R; Bear CE; Huan LJ; Griesenbach U; McKerlie C; Frndova H; Ackerley C; Gosselin D; Radzioch D; O'Brodovich H; Tsui LC; Buchwald M; Tanswell AK
J Clin Invest; 1997 Dec; 100(12):3060-9. PubMed ID: 9399953
[TBL] [Abstract][Full Text] [Related]
18. Role of CFTR, Pseudomonas aeruginosa and Toll-like receptors in cystic fibrosis lung inflammation.
Buchanan PJ; Ernst RK; Elborn JS; Schock B
Biochem Soc Trans; 2009 Aug; 37(Pt 4):863-7. PubMed ID: 19614608
[TBL] [Abstract][Full Text] [Related]
19. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
Mall MA
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
[TBL] [Abstract][Full Text] [Related]
20. Developmental paradigm for early features of cystic fibrosis.
Larson JE; Cohen JC
Pediatr Pulmonol; 2005 Nov; 40(5):371-7. PubMed ID: 15830387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
